Interaction of cardiovascular disease and neurodegeneration: transcranial Doppler ultrasonography and Alzheimer's disease

REFERENCES

• Kalaria RN. The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging 2000; 21: 321–330
   PubMed Web of Science ®Google Scholar
• de la Torre JC. Impaired cerebromicrovascular perfusion. Summary of evidence in support of its causality in Alzheimer's disease. Ann NY Acad Sci 2000; 924: 136–152
   PubMed Web of Science ®Google Scholar
• Kalaria RN. Small vessel disease and Alzheimer's dementia: Pathological considerations. Cerebrovasc Dis 2002; 13: 48–52
   PubMed Web of Science ®Google Scholar
• de la Torre JC. Alzheimer disease as a vascular disorder: Nosological evidence. Stroke 2002; 33: 1152–1162
   PubMed Web of Science ®Google Scholar
• de la Torre JC. Vascular basis of Alzheimer's pathogenesis. Ann NY Acad Sci 2002; 977: 196–215
   PubMed Web of Science ®Google Scholar
• Kalaria RN. Vascular factors in Alzheimer's disease. Int Psychogeriatr 2003; 15 (Suppl. 1): 47-52
   Google Scholar
• de la Torre JC. Is Alzheimer&s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 2004; 3: 184–190
   PubMed Web of Science ®Google Scholar
• de la Torre JC. Alzheimer's disease is a vasocognopathy: A new term to describe its nature. Neurol Res 2004; 26: 517–524
   PubMed Web of Science ®Google Scholar
• de la Torre JC. Is Alzheimer &s disease preceded by neurodegenera-tion or cerebral hypoperfusion? Ann Neurol 2005; 57: 783–784
   PubMed Web of Science ®Google Scholar
• Gaziano JM. General considerations of cardiovascular heart disease. In: Braunwald E, Zipes DP, Libby P, eds. Heart Disease: A Textbook of Cardiovascular Medicine, 6th edn, Philadelphia, PA: WB Saunders Company, 2001: pp. 1-5
   Google Scholar
• Skoog I, Kalaria RN, Breteler MM. Vascular factors and Alzheimer's disease. Alzheimer Dis Assoc Disord 1999; 13: 106–114
   Web of Science ®Google Scholar
• Fujishima M, Tsuchihashi T. Hypertension and dementia. Clin Exp Hypertens 1999; 21: 927–935
   PubMed Web of Science ®Google Scholar
• Merchant C, Tang MX, Albert S, et al. The influence of smoking on the risk of Alzheimer's disease. Neurology 1999; 52: 1408–1412
   PubMed Web of Science ®Google Scholar
• Hachinski V, Munoz D. Vascular factors in cognitive impairment—where are we now? Ann N Y Acad Sci 2000; 903: 1–5
   PubMed Web of Science ®Google Scholar
• Sparks DL, Martin TA, Gross DR, et al. Link between heart disease, cholesterol, and Alzheimer's disease: A review. Microsc Res Tech 2000; 50: 287–290
   PubMed Web of Science ®Google Scholar
• Launer IJ, Ross GW, Petrovich H, et al. Midlife blood pressure and dementia: The Honolulu-Asia aging study. Neurobiol Aging 2000; 21: 49–55
   PubMed Web of Science ®Google Scholar
• McIlroy SP, Dynan KB, Lawson JT, et al. Moderately elevated plasma homocystei ne, methyl enetetrahydrofolate reductase geno-type, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke 2002; 33: 2351–2356
   PubMed Web of Science ®Google Scholar
• Korczyn AD. Homocysteine, stroke, and dementia. Stroke 2002; 33: 2343–2344
   PubMed Web of Science ®Google Scholar
• Herrmann W, Knapp JP. Hyperhomocysteinemia: A new risk factor for degenerative diseases. Clin Lab 2002; 48: 471–481
   PubMedGoogle Scholar
• Knopman D, Boland LL, Mosley T, et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001; 56: 42–48
   PubMed Web of Science ®Google Scholar
• Peila R, Rodriguez BL, Launer Li. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 2002; 51: 1256–1262
   PubMed Web of Science ®Google Scholar
• Kivipelto M, Helkala E, Hanninen T, et al. Midlife vascular risk factors and late-life mid cognitive impairment: A population based study. Neurology 2001; 56: 1683–1689
   PubMed Web of Science ®Google Scholar
• Ott A, Slooter AJ, Hofman A, et al. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: The Rotterdam Study. Lancet 1998; 351: 1840–1843
   PubMed Web of Science ®Google Scholar
• Breteler MM. Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam scan study. Ann NY Acad Sci 2000; 903: 457–465
   PubMed Web of Science ®Google Scholar
• Breteler MM, Bots ML, Ott A, et al. Risk factors for vascular disease and dementia. Homeostatis 1998; 28: 167–173
   PubMed Web of Science ®Google Scholar
• Hofman A, Ott A, Breteler MM, et al. Atherosclerosis, apolipo-protein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 1997; 349: 151–154
   PubMed Web of Science ®Google Scholar
• Ott A, Stolk RP, Hofman A, et al. Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 1996; 39: 1392–1397
   PubMed Web of Science ®Google Scholar
• Shirey L, Summer L, O'Neill G. Alzheimer's Disease and Dementia: A Growing Challenge. Washington, DC, WA: National Academy on Aging Society, 2000. Available at: http:// www.agingsociety.org/agingsociety/pdf/alzheimers.pdf
   Google Scholar
• Sparks DL, Hunsaker JC, Scheff SW, et al. Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol Aging 1990; 11: 601–607
   PubMed Web of Science ®Google Scholar
• Roher AE, Esh C, Kokjohn TA, et al. Circle of Willis atherosclerosis is a risk factor for sporadic Alzheimer's disease. Arterioscler Thromb Vasc Biol 2003; 23: 2055–2062
   PubMed Web of Science ®Google Scholar
• Roher AE, Esh C, Rahman A, et al. Atherosclerosis of cerebral arteries in Alzheimer disease. Stroke 2004; 35: 2623–2627
   PubMed Web of Science ®Google Scholar
• Kalback W, Esh C, Castano EM, et al. Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease. Neurol Res 2004; 26: 525–539
   PubMed Web of Science ®Google Scholar
• Honig LS, Kukull W, Mayeux R. Atherosclerosis and AD: Analysis of data from the US National Alzheimer's Coordinating Center. Neurology 2005; 64: 494–500
   PubMed Web of Science ®Google Scholar
• Ruitenberg A, den Heijer T, Bakker SL, et al. Cerebral hypoperfu-sion and clinical onset of dementia: The Rotterdam Study. Ann Neurol 2005; 57: 789–794
   PubMed Web of Science ®Google Scholar
• Johnson KA, Mueller ST, Walshe TM, et al. Cerebral perfusion imaging in Alzheimer's disease. Use of single photon emission computed tomography and iofetamine hydrochloride 1123. Arch Neurol 1987; 44: 165–168
   PubMedGoogle Scholar
• Harris GJ, Lewis RF, Satl in A, et al. Dynamic susceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer disease: A promising alternative to nuclear medicine. AJNR Am Neuroradiol 1998; 19: 1727–1732
   PubMed Web of Science ®Google Scholar
• Johnson NA, Jahng GH, Weiner MW, et al. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impair-ment measured with arterial spin-labeling MR imaging: Initial experience. Radiology 2005; 234: 851–859
   PubMed Web of Science ®Google Scholar
• Gonzalez RG, Fischman AJ, Guimaraes AR, et al. Functional MR in the evaluation of dementia: Correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fludeoxyglu-cose F 18. AJNR Am Neuroradiol 1995; 16: 1763–1770
   PubMed Web of Science ®Google Scholar
• Spilt A, Weverling-Rijnsburger AW, Middelkoop HA, et al. Late-onset dementia: Structural brain damage and total cerebral blood flow. Radiology 2005; 236: 990–995
   PubMed Web of Science ®Google Scholar
• Franceschi M, Alberoni M, Bressi S, et al. Correlations between cognitive impairment, middle cerebral artery flow velocity and cortical glucose metabolism in the early phase of Alzheimer's disease. Dementia 1995; 6: 32–38
   PubMedGoogle Scholar
• Heun R, Knappertz V, Kraemer G. Transcranial Doppler sono-graphy in dementia of Alzheimer type. Dementia 1994; 5: 327–333
   PubMedGoogle Scholar
• Cacabelos R, Fernandez-Novoa L, Lombardi V, et al. Cerebrovascular risk factors in Alzheimer's disease: Brain hemo-dynamics and pharmacogenomic implications. Neurol Res 2003; 25: 567–580
   PubMed Web of Science ®Google Scholar
• Alvarez XA, Pichel V, Perez P, et al. Double-blind, randomized, placebo-controlled pilot study with anapsos in senile dementia: Effects on cognition, brain bioelectrical activity and cerebral hemodynamics. Methods Find Exp Clin Pharmacol 2000; 22: 585–594
   PubMedGoogle Scholar
• Alvarez XA, Mouzo R, Pichel V, et al. Double-blind placebo-control led study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelec-trical activity and cerebral perfusion. Methods Find Exp Clin Pharmacol 1999; 21: 633–644
   PubMedGoogle Scholar
• Ries F, Horn R, Hillekamp J, et al. Differentiation of multi-infarct and Alzheimer dementia by intracranial hemodynamic para-meters. Stroke 1993; 24: 228–235
   PubMed Web of Science ®Google Scholar
• Sattel H, Forstl H, Biedert S. Senile dementia of Alzheimer type and multi-infarct dementia investigated by transcranial Doppler sonography. Dementia 1996; 7: 41–46
   PubMedGoogle Scholar
• McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939–944
   PubMed Web of Science ®Google Scholar
• Magisttretti 11, Pellerin L, Martin, JL. Brain energy metabolism. In: Bloom, FE, Kupfer DJ, eds. Psychopharmacology: The fourth generation of progress, New York, NY: Raven Press, 1995: pp. 657-670
   Google Scholar
• Maalikjy AN, Borroni B, Agosti C, et al. Volume reduction in cerebral blood flow in patients with Alzheimer's disease: A sonographic study. Dement Geriatr Cogn Disord 2003; 16: 163–169
   PubMed Web of Science ®Google Scholar
• Maalikjy AN, Borroni B, Agosti C, et al. Volume cerebral blood flow reduction in pre-clinical stage of Alzheimer disease: Evidence from an ultrasonographic study. J Neurol 2005; 252: 559–563
   PubMed Web of Science ®Google Scholar
• Silvestrini M, Pasqualetti P, Baruffaldi R, et al. Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease. Stroke 2006; 37: 1010–1015
   PubMed Web of Science ®Google Scholar
• Lee AY, Jeong SH, Choi BH, et al. Pulse pressure correlates with leukoaraiosis in Alzheimer disease. Arch Gerontol Geriatr 2006; 42: 157–166
   PubMed Web of Science ®Google Scholar
• Hanon O, Haulon S, Lenoir H, et al. Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory loss. Stroke 2005; 36: 2193–2197
   PubMed Web of Science ®Google Scholar
• Qiu C, Winblad B, Viitanen M, et al. Pulse pressure and risk of Alzheimer disease in persons aged 75 years and older: A community-based, longitudinal study. Stroke 2003; 34: 594–599
   PubMed Web of Science ®Google Scholar
• Skoog I, Lernfelt B, Landahl S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347: 1141–1145
   PubMed Web of Science ®Google Scholar
• Hanon O, Latour F, Seux ML, et al. Evolution of blood pressure in patients with Alzheimer's disease: A one year survey of a French Cohort (REAL. FR). J Nutr Health Aging 2005; 9: 106–111
   PubMed Web of Science ®Google Scholar
• Verghese J, Lipton RB, Hall CB, et al. Low blood pressure and the risk of dementia in very old individuals. Neurology 2003; 61: 1667–1672
   PubMed Web of Science ®Google Scholar
• Guo Z, Viitanen M, Fratiglioni L, et al. Low blood pressure and dementia in elderly people: The Kungsholmen project. BM] 1996; 312: 805–808
   PubMed Web of Science ®Google Scholar
• Burke WJ, Coronado PG, Schmitt CA, et al. Blood pressure regulation in Alzheimer's disease.] Auton Nerv Syst 1994; 48: 65–71
   PubMedGoogle Scholar
• Tomlinson BE, Blessed G, Roth M. Observations on the brains of demented old people. J Neurol Sci 1970; 11: 205–242
   PubMed Web of Science ®Google Scholar
• Tomlinson BE, Blessed G, Roth M. Observations on the brains of non-demented old people. J Neurol Sci 1968; 7: 331–356
   PubMed Web of Science ®Google Scholar
• Rothschild D. Pathologic changes in senile psychosis and their psychobiologic significance. Am Psychiat 1937; 93: 757–788
   Google Scholar
• Rothschild D. Neuropathologic changes in arteriosclerotic psy-choses and their psychobiologic significance. Arch Neurol Psychiatr 1942; 48: 417–427
   Google Scholar
• Worm-Petersen J, Pakkenberg H. Atherosclerosis of cerebral arteries, pathological and clinical correlations. J Gerontol 1968; 23: 445–449
   PubMedGoogle Scholar
• Arab A. Plaques seniles et arteriosclerose cerebrale. Absence de rapports de dependance entre les deux processus. Estude statistique. Rev Neurol 1954; 91: 22–36
   PubMedGoogle Scholar
• Mutrux S. Contribution a l'etude histologique differentielle de la demence senile et de la maladie d'Alzheimer. Psychiatr Neurol Basel 1958; 136: 146–156
   PubMedGoogle Scholar
• Lauter H, Meyer JE. Clinical and nosological concepts of senile dementia. In: Muller C, Ciompi L, eds. Senile Dementia, Bern: Huber, 1968: pp. 13–28
   Google Scholar
• Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann Neurol 1993; 34: 752–754
   PubMed Web of Science ®Google Scholar
• Kukull WA, Schellenberg GD, Bowen JD, et al. Apolipoprotein E in Alzheimer's disease risk and case detection: A case-control study. J Clin Epidemiol 1996; 49: 1143–1148
   PubMed Web of Science ®Google Scholar
• Nalbantoglu J, Gilfix BM, Bertrand P, et al. Predictive value of apolipoprotein E genotyping in Alzheimer's disease: Results of an autopsy series and an analysis of several combined studies. Ann Neurol 1994; 36: 889–895
   PubMed Web of Science ®Google Scholar
• Liddell M, Williams J, Bayer A, et al. Confirmation of association between the e4 allele of apolipoprotein E and Alzheimer's disease. J Med Genet 1994; 31:197–200
   PubMed Web of Science ®Google Scholar
• Chartier-Harlin MC, Parfitt M, Legrain S, et al. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: Analysis of the 19q13.2 chromosomal region. Hum Mol Genet 1994; 3: 569–574
   PubMed Web of Science ®Google Scholar
• Tsai MS, Tangalos EG, Petersen RC, et al. Apolipoprotein E: Risk factor for Alzheimer disease. Am J Hum Genet 1994; 54: 643–649
   PubMed Web of Science ®Google Scholar